Prevention of organ toxicity involves risk assessment, regulation, and the development of safer compounds. Risk assessment includes identifying potential toxicants and evaluating their effects under various exposure conditions. Regulatory bodies establish guidelines and limits for exposure to hazardous substances. Pharmaceutical development focuses on minimizing adverse effects through structure-activity relationship studies and optimizing drug delivery systems. Monitoring and reducing environmental exposure to pollutants also play a critical role.
